Fatima Naseer
Psychiatry · Camdenton, MONPI 1639281223
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $981 and has fallen 87.4% since, to $124 in 2023.
Across 150 payments — averaging $13.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$472
- Neurocrine Biosciences, Inc.$317
- Sunovion Pharmaceuticals Inc.$283
- Johnson & Johnson$220
- Teva Pharmaceuticals USA, Inc.$195
- Alkermes, Inc.$158
- plus $401 from 8 others
What the payments were for
- Food & beverage$2,048100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 39 | $472 |
| Neurocrine Biosciences, Inc. | 24 | $317 |
| Sunovion Pharmaceuticals Inc. | 20 | $283 |
| Johnson & Johnson | 23 | $220 |
| Teva Pharmaceuticals USA, Inc. | 8 | $195 |
| Alkermes, Inc. | 11 | $158 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $90 |
| AbbVie | 3 | $52 |
| Lundbeck LLC | 4 | $51 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| Indivior Inc. | 3 | $46 |
| Shire North American Group Inc | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Corium, LLC | 2 | $26 |
How this compares
$2,048 in reported general payments places this provider in the 75th percentile of 680 psychiatry providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 26 | $111 |
| Bupropion XlBupropion Hcl | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Camdenton
- Gregory MattingleySaint Charles$4.7M
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- Brian BarashKansas City$856K
- Casey ProughLees Summit$615K
- George GrossbergSaint Louis$501K
- Shahid InsafBranson$416K
- Ahmed TaranissiMexico$343K
- Ravdeep KhanujaPoplar Bluff$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.